Publikace
- Slower molecular response to treatment predicts poor outcome in patients with TEL/AML1 positive acute lymphoblastic leukemia - Prospective real-time quantitative reverse transcriptase-polymerase chain reaction study2003 | 1. lékařská fakulta, 2. lékařská fakulta, Fakulta tělesné výchovy a sportu
- Significance of real-time quantitative polymerase chain reaction detection of p16 gene deletions in childhood acute lymphoblastic leukemia2002 | 2. lékařská fakulta
- Genomic DNA-based measurable residual disease monitoring in pediatric acute myeloid leukemia: unselected consecutive cohort study2024 | 2. lékařská fakulta
- Chimeric JAK2 Kinases Trigger Non-uniform Changes of Cellular Metabolism in BCR-ABL1-like Childhood ALL2023 | 2. lékařská fakulta, Ústřední knihovna
- NGS better discriminates true MRD positivity for the risk stratification of childhood ALL treated on MRD-based protocol2023 | 2. lékařská fakulta
- Clonal origin and development of high hyperdiploidy in childhood acute lymphoblastic leukaemia2023 | 2. lékařská fakulta
- The KMT2A recombinome of acute leukemias in 20232023 | 2. lékařská fakulta
- Posttreatment positivity of BCR::ABL1 in acute lymphoblastic leukemia: Should we keep track?2023 | 2. lékařská fakulta
- Minimal residual disease and outcome characteristics in infant KMT2A-germline acute lymphoblastic leukaemia treated on the Interfant-06 protocol2022 | 2. lékařská fakulta
- Measurable residual disease analysis in paediatric acute lymphoblastic leukaemia patients with ABL-class fusions2022 | 2. lékařská fakulta
Loading network view...